MorphRx.ai presents a self-driving lab platform that combines generative AI with robotics to accelerate therapeutic discovery across multiple modalities, including small molecules, PROTACs, antibodies, and RNA therapeutics. The site outlines the company’s goal of designing, synthesizing, and testing candidates in real time through automated synthesis, AI-driven design, and closed-loop experimentation for accelerated drug development.